Mereo BioPharma Group (MREO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.11
0.05 (1.63%)
At close: Jan 15, 2025, 12:09 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Cash & Equivalents | 57.42M | 56.33M | 94.30M | 23.47M | 16.35M | 25.04M | 50.04M | 53.58M | 79.68M |
Short-Term Investments | n/a | 51.10M | 569.00K | 547.00K | 544.00K | 2.50M | 2.50M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | -25.95M | -27.09M | -33.22M | -56.01M | n/a | n/a | n/a | n/a |
Receivables | 3.73M | 2.75M | 1.42M | 1.02M | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | -2.67M | -1.82M | -4.64M | -11.98M | -293.33K | -2.50M | -53.92M | n/a |
Other Current Assets | 2.61M | 4.27M | 5.03M | 1.62M | 2.11M | 6.95M | 10.63M | 7.20M | 1.60M |
Total Current Assets | 63.76M | 62.13M | 99.32M | 29.73M | 30.43M | 34.50M | 63.18M | 60.78M | 81.28M |
Property-Plant & Equipment | 1.65M | 1.83M | 2.53M | 1.57M | 11.56M | 148.94K | 153.36K | 173.87K | 204.52K |
Goodwill & Intangibles | 1.09M | 24.12M | 24.56M | 31.65M | 44.46M | 32.63M | 33.01M | 25.81M | 25.81M |
Total Long-Term Assets | 2.74M | 25.95M | 27.09M | 33.22M | 56.01M | 32.78M | 33.16M | 25.99M | 26.02M |
Total Assets | 66.50M | 88.08M | 126.42M | 62.95M | 86.45M | 67.28M | 96.34M | 86.76M | 107.30M |
Account Payables | 2.35M | 3.49M | 2.29M | 2.94M | 5.88M | 5.57M | 2.64M | 1.23M | 1.08M |
Deferred Revenue | n/a | n/a | 8.37M | n/a | 5.45M | -177.71K | -163.72K | n/a | n/a |
Short-Term Debt | 652.00K | 11.59M | 622.00K | 636.00K | 17.73M | 6.84M | 1.94M | n/a | n/a |
Other Current Liabilities | 5.83M | 9.43M | 7.92M | 7.95M | 6.09M | 3.60M | 8.27M | 1.87M | 4.81M |
Total Current Liabilities | 9.49M | 24.68M | 12.54M | 8.56M | 29.88M | 16.18M | 9.62M | 3.21M | 2.82M |
Long-Term Debt | 5.30M | 1.48M | 1.75M | 17.30M | 19.26M | 14.65M | 18.81M | 3.13M | 2.80M |
Other Long-Term Liabilities | 1.18M | 54.00K | 36.04M | 59.98M | 24.34M | 3.68M | 5.42M | 1.17M | 141.31K |
Total Long-Term Liabilities | 6.48M | 1.53M | 25.87M | 69.35M | 16.32M | 18.33M | 24.23M | 4.30M | 2.94M |
Total Liabilities | 15.96M | 26.21M | 38.41M | 77.92M | 46.19M | 34.51M | 33.85M | 7.51M | 5.76M |
Total Debt | 5.95M | 12.77M | 16.76M | 17.94M | 32.42M | 21.48M | 20.75M | 3.13M | 2.80M |
Common Stock | 2.77M | 1.88M | 1.75M | 1.02M | 294.00K | 213.72K | 213.28K | 193.02K | 59.22K |
Retained Earnings | -419.63M | -331.16M | -296.97M | -309.69M | -146.06M | -111.22M | -79.32M | -33.58M | -12.19M |
Comprehensive Income | -17.48M | 137.91M | 136.90M | 133.22M | 47.32M | 25.59M | 23.36M | 12.67M | n/a |
Shareholders Equity | 50.54M | 61.87M | 88.00M | -14.97M | 40.26M | 32.77M | 62.48M | 79.26M | 101.54M |
Total Investments | n/a | 51.10M | 569.00K | 547.00K | 544.00K | 2.50M | 2.50M | n/a | n/a |